Literature DB >> 30904787

A comparative digital morphometric study of lung tissue in saltwater and freshwater drowning.

Rosario Barranco1, Claudia Castiglioni2, Francesco Ventura3, Tony Fracasso2.   

Abstract

Acute pulmonary emphysema (APE) is describedin cases of drowning and can be considered as a sign of vitality. In our experience, however, APE is not very evident in cases of saltwater drowning. The present study aims at investigating whether APE is present in both fresh and saltwater drowning by means of digital morphometric analysis of lung tissue. We investigated and compared a group of saltwater drowning and a group of freshwater drowning, while cases of acute external bleeding were investigated as negative control group. Tissue samples from each pulmonary lobe were collected during autopsy and examined by optical microscope. The area of alveolar spaces was calculated by means of image analysis software, recording the mean alveolar area (MAA) for each group. MAA was 24,852 μm2 in the saltwater drowning group, 34,133 μm2 in the freshwater drowning group and 21,871 μm2 in the negative control group. The MAA in freshwater drowning was significantly higher than in saltwater drowning and controls. No statistical differences were observed between saltwater drowning and controls. The results of this study suggest that APE is not a typical sign of death by saltwater drowning.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute pulmonary emphysema; Forensic pathology; Freshwater drowning; Morphometric digital analysis; Saltwater drowning

Mesh:

Year:  2019        PMID: 30904787     DOI: 10.1016/j.forsciint.2019.03.004

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  1 in total

1.  Immunohistochemical renal expression of aquaporin 2, arginine-vasopressin, vasopressin receptor 2, and renin in saltwater drowning and freshwater drowning.

Authors:  Rosario Barranco; Francesco Ventura; Tony Fracasso
Journal:  Int J Legal Med       Date:  2020-04-02       Impact factor: 2.686

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.